Crescent Biopharma Q3 EPS $(0.90) Misses $(0.72) Estimate, Sales $3.117M Beat $312.500K Estimate
Benzinga Newsdesk 7 hours ago
NewsEarningsEarnings BeatsEarnings Misses
Crescent Biopharma (NASDAQ:CBIO) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.72) by 25 percent. This is a 29.13 percent increase over losses of $(1.27) per share
Crescent Biopharma (NASDAQ:CBIO) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.72) by 25 percent. This is a 29.13 percent increase over losses of $(1.27) per share from the same period last year. The company reported quarterly sales of $3.117 million which beat the analyst consensus estimate of $312.500 thousand by 897.44 percent.